Skip to main content
. 2024 Jun 2;16:17588359241253115. doi: 10.1177/17588359241253115

Figure 5.

Figure 5.

Incidence rates (and 95% confidence intervals) of endocrine treatment-related outcomes in breast cancer patients on aromatase inhibitors.

Dashed line indicates start of pandemic. Gaps between values indicate absence of data for the corresponding months.